These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2362633)

  • 1. Reduction of proteinuria by adrenalectomy and its restoration by glucocorticoids in rats bearing functioning pituitary tumor.
    Maeda T; Furukawa I; Suzuki T; Mori H
    Nephron; 1990; 55(2):181-6. PubMed ID: 2362633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinuria induced by transplantable rat pituitary tumor MtT SA5. Model for homologous protein-overload proteinuria.
    Mori H; Yamashita H; Nakanishi C; Koizumi K; Makino S; Kishimoto Y; Hayashi Y
    Lab Invest; 1986 Jun; 54(6):636-44. PubMed ID: 3713138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone.
    Kahn CR; Goldfine ID; Neville DM; De Meyts P
    Endocrinology; 1978 Oct; 103(4):1054-66. PubMed ID: 217665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome.
    Agrawal S; Chanley MA; Westbrook D; Nie X; Kitao T; Guess AJ; Benndorf R; Hidalgo G; Smoyer WE
    Sci Rep; 2016 May; 6():24392. PubMed ID: 27142691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mineralocorticoids and glucocorticoids on compensatory adrenal growth in rats.
    Phillips R; Crock C; Funder J
    Am J Physiol; 1985 Apr; 248(4 Pt 1):E450-6. PubMed ID: 3985143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent interaction between glucocorticoids and growth hormone-releasing factor in vivo.
    Wehrenberg WB; Baird A; Ling N
    Science; 1983 Aug; 221(4610):556-8. PubMed ID: 6408735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy with estrogen and testosterone eliminates the aggravating effect of estrogen replacement therapy on glomerular injury in hypercholesterolemic female Imai rats.
    Ikeda Y; Sakemi T; Tomiyoshi Y; Miyazono M
    Kidney Blood Press Res; 2000; 23(1):27-34. PubMed ID: 10567851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged hypothermia after phenobarbital-induced anesthesia in adrenalectomized rats.
    Janocko L; Mycek MJ
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1651-8. PubMed ID: 3737633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal pathology in rats bearing tumour-secreting growth hormone.
    Kawaguchi H; Itoh K; Mori H; Hayashi Y; Makino S
    Pediatr Nephrol; 1991 Jul; 5(4):533-8. PubMed ID: 1911134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid regulation of growth hormone (GH) secretagogue-induced growth responses and GH secretagogue receptor expression in the rat.
    Thomas GB; Bennett PA; Carmignac DF; Robinson IC
    Growth Horm IGF Res; 2000 Feb; 10(1):45-52. PubMed ID: 10753592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and morphological characteristics of transplantable rat pituitary tumors established in nude mice.
    Makino S; Mori H; Koizumi K; Yamashita H; Hayashi Y; Aono T; Matsumoto K
    Cancer Res; 1984 Oct; 44(10):4487-95. PubMed ID: 6540621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
    van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
    Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression of the receptor for growth-hormone-releasing hormone is physiologically regulated by glucocorticoids and estrogen.
    Lam KS; Lee MF; Tam SP; Srivastava G
    Neuroendocrinology; 1996 Jun; 63(6):475-80. PubMed ID: 8793888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury.
    Remuzzi A; Puntorieri S; Alfano M; Macconi D; Abbate M; Bertani T; Remuzzi G
    Lab Invest; 1992 Nov; 67(5):572-9. PubMed ID: 1434536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of hypothalamic and pituitary corticotropin-releasing hormone receptor messenger ribonucleic acid by adrenalectomy and glucocorticoids.
    Luo X; Kiss A; Rabadan-Diehl C; Aguilera G
    Endocrinology; 1995 Sep; 136(9):3877-83. PubMed ID: 7649095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-like actions of medroxyprogesterone acetate upon MtTW15 rat mammosomatotropic pituitary tumors.
    Winneker RC; Parsons JA
    Endocrinology; 1981 Jul; 109(1):99-105. PubMed ID: 6453713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of renin secretion in conscious adrenalectomized rats with glucocorticoid-induced hypertension.
    Burris JF; Waeber B; Nussberger J; Brunner HR
    Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):292-301. PubMed ID: 3521516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of pituitary insulin-like growth factor-I messenger ribonucleic acid levels in rats harboring somatomammotropic tumors: implications for growth hormone autoregulation.
    Fagin JA; Brown A; Melmed S
    Endocrinology; 1988 May; 122(5):2204-10. PubMed ID: 3359980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent effects of glucocorticoid on the gene expression of vasoactive intestinal peptide in the rat cerebral cortex and pituitary.
    Lam KS; Srivastava G; Tam SP
    Neuroendocrinology; 1992 Jul; 56(1):32-7. PubMed ID: 1641071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.